trachomatis is a leading cause of sexully transmitted disease, frequently occurring worldwide. It has been estimated that 25% of infected men and 50-80% of women may be asymptomatic, e-4 These individuals have a risk to further transmit the infection without any knowledge of the disease. In addition, the asymptomatic infection may lead to severe complications including infertility due to tubal damage, chronic abdominal pain, or chronic arthritis. Testing first void urine, made possible by the sensitive assays relying on the amplification of chlamydial DNA, s,6 complements the earlier established methods, e.g., isolation in cell culture and detection of chlamydial antigen. 7 ,s The diagnosis of past or complicated infections is not usually possible by using these methods as swabbing the infected site is not possible without invasive procedures or chlamydial particles may not be present at the site.
Another method to diagnose complicated chlamydial infections is to measure antibodies against C. trachomatis in serum or secretions. 9 The "gold standard" of chlamydia serology is the microimmunofluorescenc (MIF) test. 1 Several enzyme irnmunoassay (EIA)-based tests have been developed for the detection of C. trachomatis antibodies. 11,1z However, during chlamydial infection, antibodies are also formed against the common antigenic epitopes present in all members of the genus Chlamydia. When whole bacteria are used as antigen in EIAs, the detection of these cross-reacting antibodies makes species-specific diagnosis difficult.
We have developed a synthetic peptide-based C. trachomatis 
DISCUSSION
Synthetic peptides offer an alternative method to create highly specific and sensitive serological tests for diagnosis of microbial infections. 13 They provide a possibility to design site-specific antigenic determinants for distinction between type-specific antibodies.
14 Since the MOMP of C. trachomatis is an antigenically complex protein having crossreactive and species-specific epitopes, is the specificity can be achieved only by using synthetic peptide as an antigen. 16 For a more accurate determination of species-specific epitopes with the highest sensitivity, the continuous antigenic epitopes of C. trachomatis MOMP polypeptide were studied by using the epitope scanning method. Systematic scanning with overlapping peptides derived from the MOMP polypeptide showed species-specific antigenic determinants, which reacted with C. trachomatis antibody positive human sera. 17 The difficulty in the serology of chlamydial infections is the close relationship of C. trachomatis and C. pneurnoniae. 8 Common antigenic structures also in major polypeptides such as MOMP and kd60 may lead to the cross-reactions interfering with the diagnosis of C. trachomatis seroreactivity. Specificity of the assay is a question of importance in chlamydial serology since the epidemiology and transmission routes of C. trachomatis and C. pneu- 
